Corbus Pharmaceuticals Holdings (CRBP) Stock Highlights

49.33 | -3.08%

2024-09-19 04:01:24

Corbus Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for endocannabinoid or immune system. The companys lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus.

Statistics

Range Today

47.95 51.25

Volume Today 345.5K

Range 1 Year

3.03 61.9

Volume 1 Year 90.74M

Range 3 Year

2.11 61.9

Volume 3 Year 143.86M

Range 10 Year

2.11 323.4

Volume 10 Year 237.76M

Highlights

Market Capitalization 672.17M (small)

Floating Shares 9.66M

Current Price 49.33

Price To Earnings -8.94

Price To Book 5.11

Earnings Per Share -5.79

Payout Ratio 0%

Performance

Latest -3.08%

1 Month -7.22%

3 Months +14.64%

6 Months +14.38%

1 Year +623.31%

3 Years +53.68%

5 Years -70.58%

10 Years -45.19%

Benchmarks

Market Capitalization

209 / 368

Gross Profits

168 / 278

Total Revenue

0 / 300

Total Rank

5 / 368

Free Cashflow

135 / 352

Performance 5 years

215 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.